Latest filing published 06 May 2014 for Stagwell Inc.
No signal scores available.
Based on 46 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert Kamerschen is a declared insider at 6 companies; the most frequent names are Stagwell Inc, R H Donnelley Corp and IMS Health Inc. The record holds 117 filings, for trades running from 14 February 2006 to 5 May 2014.
Both buying and selling appear: 56 purchases worth €2.9M, against 2 sales worth €321k. Taken together, the purchases exceed the sales by €2.5M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 46 share grants and 4 option exercises. 2014 to date brings 4 purchases and no sales.
A typical purchase (the median) is worth €32k. After 46 purchases with a full 90-day history, the hit rate stands at 59% and the median 90-day move at +2.0%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 6 May 2014, the filings show a share grant in Stagwell Inc. The clock since the last published purchase (6 May 2014) now reads 4,554 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 113 declarations